Federal grants to Myosin Therapeutics Inc
Myosin Therapeutics Inc in Jupiter, Florida received $9.8 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Cancer Treatment Research, with $5.2 million. In fiscal 2025 it was awarded $4.9 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$9.8 million
- Awards5
- Awarded in FY 2025$4.9 million
- Largest award$3.2 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $325,429 |
| FY 2022 | 1 | $1.2 million |
| FY 2023 | 2 | $2.1 million |
| FY 2024 | 1 | $1.3 million |
| FY 2025 | 4 | $4.9 million |
Programs that fund Myosin Therapeutics Inc
| Program | Awards | Amount |
|---|---|---|
| Cancer Treatment Research | 3 | $5.2 million |
| Drug Use and Addiction Research Programs | 2 | $4.7 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 5 | $9.8 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Development of a first-in-class nonmuscle myosin II inhibitor to prevent substance use disorder relapse - project summary in 2018, over 1 million people in the U.S. Qualified as having a methamphetamine (METH) use disorder and rates of meth use are surging, largely in response to the opioid epidemic | Drug Use and Addiction Research Programs | September 21, 2021 | $3.2 million |
| MT-125 for the therapeutic treatment of glioblastoma - project summary an area of significant unmet need is the treatment of glioblastoma (GBM), an aggressive, fast-growing and lethal brain cancer that represents 48% of all malignant brain tumors. Untreated, gbm is fatal within three months, and due | Cancer Treatment Research | March 31, 2023 | $2.7 million |
| Phase 0/i dose escalation trial of MT-125 monotherapy in recurrent high-grade gliomas - project summary an area of significant unmet need is the treatment of glioblastoma (GBM), an aggressive, fast-growing and lethal brain cancer that represents half of all malignant brain tumors. Untreated, gbm is | Cancer Treatment Research | August 7, 2025 | $2.2 million |
| Phase 0/1B clinical trial of novel therapeutic agent MT-110 for the reduction of methamphetamine use - part 2 - project summary as of 2023, close to 2 million individuals in the united states are identified as having methamphetamine use disorder (MUD), with methamphetamine use rising significantly. | Drug Use and Addiction Research Programs | March 18, 2025 | $1.5 million |
| Development of drug product to support a phase 0/1B dose escalation trial of MT-125 in recurrent high grade gliomas - project summary glioblastoma (GBM), marked by its aggressive, fast-growing nature and high mortality rate, makes up nearly half of all malignant brain tumors. Survival is limited to | Cancer Treatment Research | September 16, 2025 | $249,417 |
Questions people ask
How much federal grant money does Myosin Therapeutics Inc get?
$9.8 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Myosin Therapeutics Inc the most?
The Department of Health and Human Services, with $9.8 million in 5 awards.
What is Myosin Therapeutics Inc's largest federal grant?
$3.2 million under Drug Use and Addiction Research Programs, with its first action in the period on September 21, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Myosin Therapeutics Inc?
Its largest are Cancer Treatment Research and Drug Use and Addiction Research Programs.
Other grant recipients in Jupiter
- Max Planck Florida Corp
- Parametric Solutions Inc.
- The Scripps Research Institute
- Town of Jupiter
- Deluge Biotechnologies Inc
- Alpha Young LLC
Largest federal grant recipients in Florida · Federal grants in Florida